Independent · No industry funding · Open access

Mapping the therapeutic potential of existing medicines
— openly, and with the evidence attached.

The Open Source Medicine Foundation is an independent research non-profit. We map druggable targets, candidate repurposed compounds, natural products and registered clinical trials for 100+ chronic conditions, plus the exercise, device and supplement trials for Long COVID and post-vaccine syndromes, and publish all of it free, with every source linked.

Explore the Research Tracker Read research notes

Research information for patients, clinicians and scientists — not medical advice.

400+peer-reviewed papers by our directors 100+conditions mapped DailyPubMed & trial updates 100%open access, every source linked

Plain-language summaries of the evidence

What the published research says about Long COVID, post-vaccine syndromes and chronic illness, written to be read without a medical degree, plus registered trials you can raise with your clinician.

Druggable targets, biomarkers and trials, graded by evidence

A daily-updated tracker: gene targets graded on DGIdb, Open Targets and ChEMBL evidence, biomarker atlases, registered trials and a repurposing explorer for candidate compounds. Downloadable and citable.

An integrated roadmap: discovery, testing, access, decisions

Open evidence infrastructure that connects candidate therapeutics, biomarkers, decentralised trials, regulatory access and decision intelligence. Open, collaborative and forkable by design.

All research notes →  ·  Full research library →

Two directors, 400+ publications

Executive Director Matthew Halma (biophysics, pharmacoepidemiology) and Scientific Director Prof Jack A. Tuszynski (Allard Chair in Oncology, University of Alberta), with active clinical trial programmes.

Meet the team →

Cited by national advisory committees

Our work on post-acute COVID vaccination syndrome (PACVS) is cited by national advisory bodies, and our directors have published across candidate repurposed compounds for chronic conditions, post-viral syndromes, and environmental health and drug safety.

See our experience →

PACVS Research Summit

An international consensus initiative bringing together researchers working on diagnostic criteria for post-acute COVID vaccination syndrome.

Visit the summit site →
  1. Clinical

    Evidence from studies in people.

  2. Mechanistic

    A documented molecular action on the target.

  3. Correlative

    An association reported in the literature without a demonstrated mechanism.

Where a page lists a compound in a trial, it is reporting that a trial exists, not that the compound works. Read the full editorial policy →

Is this medical advice?

No. We publish research information: peer-reviewed research, plain-language research notes and compiled data built from public databases. We do not publish treatment recommendations, dosing guidance or product endorsements. Talk to your own clinician before acting on anything you read here.

Are you the Open Medicine Foundation?

No. The Open Source Medicine Foundation (OSMF) is an independent non-profit registered in Tallinn, Estonia. It is not affiliated with the Open Medicine Foundation, a separate charity that funds ME/CFS research.

Do you cover options other than medicines?

Yes. Beyond medicines lists the exercise, behavioural, device and supplement interventions being tested in registered post-viral trials, and RepurpOS grades the natural products linked to each condition. Being studied is not the same as working, and supplements can interact with medicines.

How do you choose and grade evidence?

Studies come from PubMed-indexed, peer-reviewed publications; trials from ClinicalTrials.gov; targets and compounds from DGIdb, Open Targets and ChEMBL. Relationships are graded clinical, mechanistic or correlative. The editorial policy sets out every rule.

How is the foundation funded?

By individual donations and research grants. It accepts no funding from pharmaceutical, nutraceutical or device companies, and does not sell products. A gift never unlocks content: data, tools and safety information stay free for everyone. Ways to support

I found an error. How do I report it?

Write to the contact address or open an issue on the tracker's GitHub repository (see Contribute). We aim to respond within seven days. Material corrections are made on the page with a note of what changed.

Can I reuse the data?

Yes. Data the foundation creates is openly licensed (CC BY 4.0) and comes with a "Cite this page" box, JSON downloads and an embed widget, so other sites and papers can build on it. Material from third-party sources, such as ChEMBL or ClinicalTrials.gov, keeps its original terms.

The OSMF Network